EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential

Mohammad Hosein Nemati iD, Esmaeil Yazdanpanah, Roya Kazemi, Niloufar Orooji, Sepehr Dadfar iD, Valentyn Oksenych iD, Dariush Haghmorad iD

Biology · 17.04.2025 · 14 (4) · 435

DOI: 10.3390/biology14040435 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 17.04.2025. Verfasst von Mohammad Hosein Nemati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Semnan University of Medical Sciences, Semnan 3514799442, Iran. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a well-known, chronic autoimmune disorder of the central nervous system (CNS) involving demyelination and neurodegeneration. Research previously conducted in the area of the gut microbiome has highlighted it as a critical contributor to MS pathogenesis. Changes in the commensal microbiota, or dysbiosis, have been shown to affect immune homeostasis, leading to elevated levels of pro-inflammatory cytokines and disruption of the gut–brain axis. In this review, we provide a comprehensive overview of interactions between the gut microbiota and MS, especially focusing on the immunomodulatory actions of microbiota, such as influencing T-cell balance and control of metabolites, e.g., short-chain fatty acids. Various microbial taxa (e.g., Prevotella and Faecalibacterium) were suggested to lay protective roles, whereas Akkermansia muciniphila was associated with disease aggravation. Interventions focusing on microbiota, including probiotics, prebiotics, fecal microbiota transplantation (FMT), and dietary therapies to normalize gut microbial homeostasis, suppress inflammation and are proven to improve clinical benefits in MS patients. Alterations in gut microbiota represent opportunities for identifying biomarkers for early diagnosis, disease progression and treatment response monitoring. Further studies need to be conducted to potentially address the interplay between genetic predispositions, environmental cues, and microbiota composition to get the precise mechanisms of the gut–brain axis in MS. In conclusion, the gut microbiota plays a central role in MS pathogenesis and offers potential for novel therapeutic approaches, providing a promising avenue for improving clinical outcomes in MS management.

Schlagwörter

Stichwörter der Autor:innen

dysbiosisgut microbiotaimmune modulationmultiple sclerosistherapeutic interventions

Autor:innen und Institutionen

  • Student Research Committee, Semnan University of Medical Sciences, Semnan 3514799442, Iran.
  • Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan 3514799442, Iran.
  • Immunology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
  • Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.

ORCID-Profile: Mohammad Hosein Nemati, Sepehr Dadfar, Valentyn Oksenych, Dariush Haghmorad

Zitieren

APA

Nemati, M. H., Yazdanpanah, E., Kazemi, R., Orooji, N., Dadfar, S., Oksenych, V., & Haghmorad, D. (2025). Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential. Biology, 14(4), 435. https://doi.org/10.3390/biology14040435

Vancouver

Nemati MH, Yazdanpanah E, Kazemi R, Orooji N, Dadfar S, Oksenych V, et al. Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential. Biology. 2025;14(4):435. doi:10.3390/biology14040435

BibTeX
@article{Nemati2025,
  author = {Nemati, Mohammad Hosein and Yazdanpanah, Esmaeil and Kazemi, Roya and Orooji, Niloufar and Dadfar, Sepehr and Oksenych, Valentyn and Haghmorad, Dariush},
  title = {Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential},
  journal = {Biology},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {435},
  doi = {10.3390/biology14040435}
}
Kostenlos starten →